logo
episode-header-image
Nov 2025
48m 13s

How AI Will Accelerate Breakthroughs in ...

Conviction
About this episode
tail spinning
Up next
Oct 29
Taking on ServiceNow: Coding Agents the Rest of Us with Serval Co-Founder and CEO Jake Stauch
What happens when you put code-generation agents in the hands of enterprise IT teams? With Serval, you get a system where it's easy for everyone to be a builder. Sarah Guo and Elad Gil sit down with Serval co-founder and CEO Jake Stauch to analyze his company’s direct challenge t ... Show More
38m 5s
Oct 23
Democratizing Security for the Agentic Web with Cloudflare CTO Dane Knecht
In the transition to the agentic web, security has become an afterthought. Now, organizations are racing to figure out what AI security means, and how to keep their data safe. Live from Cloudflare Connect, Sarah Guo sits down with Cloudflare CTO Dane Knecht to discuss the changin ... Show More
41m 23s
Oct 22
The New Apex Predator: CrowdStrike CEO George Kurtz on Adversaries Armed With AI Agents
Adversaries are already running AI agents, and the fastest attacks now play out in seconds. Sarah Guo and Elad Gil sit down with CrowdStrike president and CEO George Kurtz on what AI-equipped attackers mean for enterprise security. George explains how agents are flattening the ad ... Show More
45m 27s
Recommended Episodes
Feb 2025
Understanding AI's Expanding Role in Drug Discovery and Life Sciences R&D - Liran Belenzon of BenchSci
<p><span data-preserver-spaces="true">Today's guest is Liran Belenzon, Co-founder and CEO of BenchSci. BenchSci is a global leader in AI solutions for preclinical R&D that helps decipher complex biomedical research using proprietary technology. Liran joins us to discuss how AI is ... Show More
19m 3s
Sep 2025
Faster Science, Better Drugs
<p>Can we make science as fast as software? </p><p>In this episode, Erik Torenberg talks with Patrick Hsu (cofounder of Arc Institute) and a16z general partner Jorge Conde about Arc’s “virtual cells” moonshot, which uses foundation models to simulate biology and guide experiments ... Show More
56m 26s
Mar 2025
AI in Biopharma Innovation and Regulatory Challenges - with Nishtha Jain of Takeda Pharmaceuticals
<p>Today's guest is Nishtha Jain, Head of Innovation and Digital Technology at Takeda Pharmaceuticals. Nistha returns to the program to discuss the transformative impact of AI across the pharmaceutical value chain. She and Emerj Editorial Director Matthew DeMello explore how AI i ... Show More
26m 36s
Apr 2024
How AI is Accelerating the Search for New Medicines
Why is the process of creating a new and highly beneficial pharmaceutical drug so difficult? What are the hurdles researchers face when trying to identify a new drug? Why are side effects so challenging to predict? Why are pharmaceutical drugs so expensive? In today's episode, we ... Show More
23m 25s
Jan 2019
a16z Podcast: The Science and Business of Innovative Medicines
<p>with Vas Narasimhan (@vasnarasimhan), Jorge Conde (@jorgecondebio), Vijay Pande (@vijaypande), and Sonal Chokshi (@smc90)</p><p>On average, only 1 out of 20 medicines works when we actually bring them into the human body, and these rates of success haven't moved much in the ph ... Show More
59m 2s
May 2025
From Molecules to Models: How AI is Rewriting the Rules of Drug Discovery | Will Snow with Dr. Alex Aliper at Dubai AI Festival
tail spinning
14m 37s
May 2024
GSK’s Use of AI in Vaccine Tech, Drug Discovery
GSK’s Chief Digital and Technology Officer Shobie Ramakrishnan discusses how the company is leveraging AI and data models for vaccine development and drug discovery in this episode of Bloomberg Intelligence’s Tech Disruptors podcast. BI’s Health-Care Analyst Sam Fazeli and Techno ... Show More
42m 42s
Aug 2024
Driving Manufacturing, Supply Chain, and Marketing Synergies with AI - with Kartik Pant and Shreyas Becker of Sanofi
<p>Today's guests include two senior executives from Sanofi's manufacturing division, Head of Data & AI for Manufacturing & Supply Chain Kartik Pant and Head of AI & Data Products, Manufacturing & Supply Shreyas Becker, respectively. The pair join us on today's podcast to identif ... Show More
17m 47s
Sep 2023
AI Revolution: Digital Biology with insitro's Daphne Koller
Daphne Koller is the founder and CEO of insitro, a company using AI and machine learning to engineer drug discovery. In this conversation with a16z's Vijay Pande, she discusses how an LLM for cells could revolutionize drug discovery and how to bridge the technological and cultura ... Show More
22m 28s
Mar 2022
Improving Drug Development Speed with AI in Life Sciences - with Emmanuel Walckenaer of YSEOP
<p>Today's guest is Emmanuel Walckenaer, CEO of YSEOP. YSEOP is a natural language generation AI vendor serving life sciences and drug development. In today's episode, Emmanuel speaks about speeding up the drug development process through the lens of the life sciences industry be ... Show More
34m 10s